Citicoline

Introducing Launch Hydrate: The Official Sports Drink of Perfect Game, Powering Athletes with Next-Gen Hydration

Retrieved on: 
Thursday, May 25, 2023
Electrolyte, Performance-enhancing substance, Operation, Partnership, Launch Pad (card game), Citicoline, Attention, Sports drink, Perfect game, Cy Young's perfect game, Athlete, Running, Memorial, Launch pad, Memory, Sport, Amazon

This partnership will provide Perfect Game participants access to Launch Hydrate's revolutionary sports drink as well as exclusive events, promotions, and products.

Key Points: 
  • This partnership will provide Perfect Game participants access to Launch Hydrate's revolutionary sports drink as well as exclusive events, promotions, and products.
  • Perfect Game announces official partnership with Launch Hydrate, a leading innovator in the sports nutrition industry.
  • "We are thrilled to partner with Launch Hydrate as the official sports drink of Perfect Game," said Perfect Game CEO, Rob Ponger.
  • "We are excited to introduce Launch Hydrate to the athletes participating in Perfect Game's East Cobb activation," said Dillon Houstoun, VP of Finance and Operations for Launch Hydrate.

Kyowa Hakko Explores Evolving Consumer Viewpoints on Cognitive, Immune Health

Retrieved on: 
Monday, April 24, 2023
Drink, Quality of life, Citicoline, Immunity, MBA, Brain, Attention, RD, Pulse, CENTR, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Kyōwa, Kyowa Kirin, Trust, Energy drink, Food, Disease, Retail, Online shopping, Vaccine, Nursing, Dietary supplement, Ipsos

NEW YORK, April 24, 2023 /PRNewswire-PRWeb/ -- Immune and cognitive health represent two of the brightest opportunities for product development in the supplement space, new consumer surveys from Kyowa Hakko indicate.

Key Points: 
  • NEW YORK, April 24, 2023 /PRNewswire-PRWeb/ -- Immune and cognitive health represent two of the brightest opportunities for product development in the supplement space, new consumer surveys from Kyowa Hakko indicate.
  • The first paper focuses on immune health, a category that has flourished as post-pandemic life returns to normal for consumers.
  • Aligned with the increasing conversation around immune health is the focus on cognitive health.
  • Ongoing trend reporting and market insight is part of the key value that Kyowa Hakko brings to its customers.

Battling Brain Fog? Opti Brain Can Help

Retrieved on: 
Monday, February 27, 2023
Allergy, Supplement, Fatigue, Trust, Tyrosine, Acetylcarnitine, Depression, Cognition, Brain, Diet, Dopamine, Citicoline, Menopause, Caffeine, Forgetting, Electronics, ADHD, Memory, COVID-19, Design

FORT LAUDERDALE, Fla., Feb. 27, 2023 /PRNewswire/ -- "Brain fog" is a term that is as common as it is vague. The colloquial concept of a fuzzy brain is used by millions around the world to describe a mental state in which a variety of symptoms contribute to sluggish cognition. This includes things like mild confusion, forgetfulness, and mental fatigue. Many conditions, such as ADHD, depression, allergies, and even menopause have been associated with brain fog, with the most infamous condition connected to a foggy state of mind being COVID-19.

Key Points: 
  • That's why Trust Supplement has created its popular nootropic blend Opti Brain .
  • Opti Brain improves mental cognition and clarity through a unique, transparent blend of ingredients optimized to boost brain power.
  • In the case of Opti Brain, this consists of a formula that includes:
    CDP-Choline and Alpha-GPC to help with neurotransmitter function.
  • With Opti Brain, customers know that they are getting a carefully formulated nootropic blend that can help them in the fight to reclaim their mental clarity.

Kyowa Hakko USA Highlights Branded Ingredients and New Innovations at SupplySide West 2022

Retrieved on: 
Tuesday, November 1, 2022
Marketing, MD, Food and Drug Administration, McGlade, MBA, Supplier, Kyowa Hakko Kirin, GRAS, PDC, Disease, Immune system, Interview, Memory, Fermentation, South by Southwest, Video, Food, NK, RD, Adolescence, Attention, Pharmaceutical industry, Vaccine, Dietary supplement, Citicoline

NEW YORK, Nov. 1, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko USA, leading international health ingredient manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products, announces featured events for IMMUSE™ a postbiotic that delivers a new, breakthrough approach to more comprehensive immune support* and Cognizin® Citicoline, a clinically studied and branded form of Citicoline.

Key Points: 
  • Following the presentation, Dr. Moday will be at the Kyowa Hakko Booth # 3065 starting at 1:00 pm to sign her recent book, The Immunotype Breakthrough.
  • Its unique mechanism of action, discovered by Kyowa Hakko's parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
  • So, we decided to make it available to everyone interested in powering their game," commented Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc.
  • Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development,
    Media interested in setting up an interview with Heather Moday MD, or Karen Todd, please drop by the Kyowa Hakko booth # 3065 or call Sue Taggart at 917.833.8101.

GLYTCH Energy® Launches Seven New Zero Sugar Formulas with Cognizin® Citicoline

Retrieved on: 
Thursday, October 13, 2022
Marketing, Memory, Disease, Science, Attention, Food and Drug Administration, Powder, Kyōwa, NEW, Food, Health, GRAS, Water, Safety, Interview, Fermentation, Video game, Dietary supplement, Citicoline

NEW YORK, Oct. 13, 2022 /PRNewswire-PRWeb/ -- GLYTCH, a revolutionary maker of wellness supplements, gamer energy and Revive hydration mixtures, that puts health and well-being first, has just launched a new energy line containing Cognizin® Citicoline. With seven flavors and more to come, these new products are targeted to the fast-growing esports market.

Key Points: 
  • NEW YORK, Oct. 13, 2022 /PRNewswire-PRWeb/ -- GLYTCH, a revolutionary maker of wellness supplements, gamer energy and Revive hydration mixtures, that puts health and well-being first, has just launched a new energy line containing Cognizin Citicoline.
  • Cognizin Citicoline, an innovative form of citicoline is a brain health nutrient found naturally in the body,* and has been clinically studied to support brain health, focus, and attention.
  • The seven GLYTCH Gaming Energy flavors are Moonbow, Predator, Falcon Smash, Vixen Lemonade, Aim Assis, Dragon Sweat and Azur Infusion.
  • A proprietary form of citicoline, Cognizin has been clinically studied to support mental energy, focus, attention, and memory.

Cognizin® Citicoline Launches "Tap Challenge" In the App Store

Retrieved on: 
Monday, August 8, 2022
Interview, Kyowa Hakko Kirin, NEW, Food and Drug Administration, Technology, Brain, Adolescence, Memory, GRAS, Tap, Attention, Marketing, Video, App Store (iOS/iPadOS), Fermentation, South by Southwest, App store, RD, MBA, Friends, McGlade, IPhone, Food, Disease, Video game, Mobile phone, Dietary supplement, Medical imaging, Pharmaceutical industry, Citicoline, Citicoline

NEW YORK, Aug. 8, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko, makers of Cognizin® Citicoline, a branded form of citicoline clinically studied to support mental energy, focus and attention*, announced today the launch of Tap Challenge, available to download in the App Store. Tap Challenge is an app that tests how quickly an individual can tap a button in 20 seconds. Great for training reflexes for more complex fighter games and games that need quick combinations, Tap Challenge truly gets your fingers moving.

Key Points: 
  • NEW YORK, Aug. 8, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko, makers of Cognizin Citicoline, a branded form of citicoline clinically studied to support mental energy, focus and attention*, announced today the launch of Tap Challenge, available to download in the App Store.
  • Tap Challenge is an app that tests how quickly an individual can tap a button in 20 seconds.
  • An innovative form of citicoline, a potent brain-health nutrient, and nootropic, Cognizin has been extensively clinically studied to support mental energy, focus, memory, and attention*.
  • A proprietary form of citicoline, Cognizin has been clinically studied to support mental energy, focus, attention, and memory.

Get Ready for Back-to-School Season with Kyowa Hakko's Cognizin® Citicoline

Retrieved on: 
Tuesday, August 2, 2022
RD, Neuron, Brain, Awareness, Fermentation, Food, GRAS, Science, Cognition, Hearing, Parent, Marketing, Centrum Praw Kobiet, MBA, Disease, Kyowa Hakko Kirin, Memory, NEW, Overalls, Attention, Pharming, Food and Drug Administration, Child, Pharmaceutical industry, Citicoline, Citicoline

NEW YORK, Aug. 2, 2022 /PRNewswire-PRWeb/ -- With, Back-to-School season right around the corner, leading international health ingredient manufacturer Kyowa Hakko makers of Cognizin® Citicoline an innovative, pure, high-quality form of citicoline that is clinically studied to support brain health, mental energy, focus, and attention* is running informational TV "Newsbreaks", starting August 1st, in key markets including NYC, Los Angeles, Chicago, Boston, and Dallas. Three of over 200 products containing Cognizin® are featured: Centrum's Focus & Clarity, Solaray's SharpMind Focus, and Nature's Bounty Active Mind.

Key Points: 
  • Three of over 200 products containing Cognizin are featured: Centrum's Focus & Clarity, Solaray's SharpMind Focus, and Nature's Bounty Active Mind.
  • Cognizin Citicoline increases an important substance in the brain called phosphatidylcholine that supports healthy brain function."
  • Cognizin Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health.
  • A proprietary form of citicoline, Cognizin has been clinically studied to support mental energy, focus, attention, and memory.

Dr. Eri Nakazaki of the Kirin Central Research Institute Wins JSBBA Award for Her Work Developing a Health Food Ingredient to Support Memory

Retrieved on: 
Wednesday, June 1, 2022
Woman, Science, Interview, Kirin Company, Research, Government budget balance, Man, Marketing, AAMI, MBA, Kyowa Hakko Kirin, GRAS, Hope, Japan Society for Bioscience, Biotechnology, and Agrochemistry, Functional food, Randomness, Kirin Holdings, Memory, Growth, RD, Health, Kyōwa, Dementia, NEW, Attention, Fermentation, Dietary supplement, Pharmaceutical industry, Biotechnology, Limited, Citicoline

NEW YORK, June 1, 2022 /PRNewswire-PRWeb/ -- Leading international health ingredient manufacturer Kyowa Hakko U.S.A., Inc. and its parent company, Kirin Holdings, announced that Dr. Eri Nakazaki of the Kirin Central Research Institute was one of the winners of the 2022 JSBBA Award for Women Corporate Researchers for her work in developing Cognizin® Citicoline, Kyowa Hakko's patented, ultra-pure, high-quality form of citicoline that is clinically studied to support brain health, mental energy, focus, and attention.

Key Points: 
  • This is the second time a member of the Kirin Central Research Institute has won the award, the first winner having been announced in 2020.
  • Citicoline is a naturally occurring brain nutrient found in the body and is especially vital to brain health.
  • The study proves that the product can be used as a functional health food ingredient to support memory.
  • Our mission is to contribute to improving the health of people through science as we discover more health benefits of food ingredients."

NutraIngredients Award Winners Europe 2022, Announced Earlier This Month

Retrieved on: 
Tuesday, May 31, 2022
GRAS, Memory, Central/North Black Forest Nature Park, Solution, Marketing, Brain, Industry, Dietary supplement, Communication, Attention, Ageing, Kyowa Hakko Kirin, Fermentation, Toy, EU, Citicoline

DUSSELDORF, Germany, May 31, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin® Citicoline for its true innovation, long-term market success, and cutting-edge research. It honored the best and brightest in ingredients, finished products, companies, people, and initiatives in the nutrition and dietary supplements industry.

Key Points: 
  • DUSSELDORF, Germany, May 31, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin Citicoline for its true innovation, long-term market success, and cutting-edge research.
  • It honored the best and brightest in ingredients, finished products, companies, people, and initiatives in the nutrition and dietary supplements industry.
  • "It's the first time Kyowa Hakko Europe has won this highly regarded NutraIngredients Award," commented Oksana Ritchie, Head of Marketing, Kyowa Hakko Europe.
  • "We submitted Cognizin to the ingredient of the year category in 2016 and were happy to become finalists, but disappointed not to be the winners.

C4 ENERGY® ANNOUNCES BOLD NEW SUPERBRAIN PERFORMANCE CLAIMS FOR ITS "SMART ENERGY" PRODUCT LINE

Retrieved on: 
Wednesday, April 27, 2022
Giant, Athlete, Citicoline, Functional beverage, University, Clinical trial, Nutrabolt Stadium, Albertsons, Caffeine, Research, DTC, The Vitamin Shoppe, Target, Sports medicine, CSCS, Student, Data analysis, QuikTrip, Giant Eagle, Female, Walmart, American College, 7-Eleven, GNC, University of Iowa, Digital, Marketing, Experiment, FACN, Safeway, Drinking, Energy, Male, Attention, C4, Kroger, Dietary supplement, Doctor of Philosophy, Publix, Amazon, Cellucor

AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Nutrabolt, a global leader in human performance and the maker of one of the nation's fastest growing performance energy drink brands, C4 Energy®, today announces new clinical trial study claims on the benefits of C4 Smart Energy, showcasing the efficacy of its better-for-you and cognitive performance energy drink. Conducted at the University of Iowa, the new study tested the cognitive and mental performance effects of C4 Smart Energy, which contains a specially-formulated combination of clinically studied ingredients, including InnovaTea®, a plant-based caffeine ingredient derived from green tea extract that delivers energy and alertness, alongside Cognizin®, a patented citicoline designed to support mental focus, attention, and recall.

Key Points: 
  • University of Iowa study backs C4 Smart Energy product benefit claims as the cognitive performance drink to deliver peak focus and energy, alongside launch of new Watermelon Burst flavor
    AUSTIN, Texas, April 27, 2022 /PRNewswire/ -- Nutrabolt , a global leader in human performance and the maker of one of the nation's fastest growing performance energy drink brands, C4 Energy , today announces new clinical trial study claims on the benefits of C4 Smart Energy, showcasing the efficacy of its better-for-you and cognitive performance energy drink.
  • The claims around C4 Smart Energy are announced just in time to celebrate the brand's latest flavor, Watermelon Burst.
  • Released just in time for summer, C4 Smart Energy Watermelon Burst has a fresh, lush, and pleasant flavor profile, ideal for a season of next-level performance and hustle.
  • "The research done behind C4 Smart Energy puts the C4 Energy brand squarely into the mental and cognitive performance market, and consumers can trust that we are continuing to forge a new frontier in creating the best-tasting performance energy products.